These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

659 related articles for article (PubMed ID: 25491504)

  • 1. Estimating preferences for treatments in patients with localized prostate cancer.
    Ávila M; Becerra V; Guedea F; Suárez JF; Fernandez P; Macías V; Mariño A; Hervás A; Herruzo I; Ortiz MJ; Ponce de León J; Sancho G; Cunillera O; Pardo Y; Cots F; Ferrer M;
    Int J Radiat Oncol Biol Phys; 2015 Feb; 91(2):277-87. PubMed ID: 25491504
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Quality of life impact of treatments for localized prostate cancer: cohort study with a 5 year follow-up.
    Ferrer M; Guedea F; Suárez JF; de Paula B; Macías V; Mariño A; Hervás A; Herruzo I; Ortiz MJ; Ponce de León J; Sancho G; Boladeras A; Ayala A; Craven-Bratle J; Ávila M; Cunillera O; Pardo Y; Alonso J; Aguiló F;
    Radiother Oncol; 2013 Aug; 108(2):306-13. PubMed ID: 23849168
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Health-related quality of life 2 years after treatment with radical prostatectomy, prostate brachytherapy, or external beam radiotherapy in patients with clinically localized prostate cancer.
    Ferrer M; Suárez JF; Guedea F; Fernández P; Macías V; Mariño A; Hervas A; Herruzo I; Ortiz MJ; Villavicencio H; Craven-Bratle J; Garin O; Aguiló F;
    Int J Radiat Oncol Biol Phys; 2008 Oct; 72(2):421-32. PubMed ID: 18325680
    [TBL] [Abstract][Full Text] [Related]  

  • 4. An assessment of quality of life following radical prostatectomy, high dose external beam radiation therapy and brachytherapy iodine implantation as monotherapies for localized prostate cancer.
    Frank SJ; Pisters LL; Davis J; Lee AK; Bassett R; Kuban DA
    J Urol; 2007 Jun; 177(6):2151-6; discussion 2156. PubMed ID: 17509305
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Patient preferences for outcomes associated with surgical management of prostate cancer.
    Smith DS; Krygiel J; Nease RF; Sumner W; Catalona WJ
    J Urol; 2002 May; 167(5):2117-22. PubMed ID: 11956454
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Management of localised prostate cancer: watchful waiting, surgery or radiation therapy, depending on the natural course, which is often relatively slow.
    Prescrire Int; 2012 Oct; 21(131):242-8. PubMed ID: 23185849
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparative Effectiveness Research in Localized Prostate Cancer: A 10-Year Follow-up Cohort Study.
    Garin O; Suárez JF; Guedea F; Pont À; Pardo Y; Goñi A; Mariño A; Hervás A; Herruzo I; Cabrera P; Sancho G; Ponce de León J; Macías V; Gutierrez C; Castells M; Ferrer M;
    Int J Radiat Oncol Biol Phys; 2021 Jul; 110(3):718-726. PubMed ID: 33388360
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Five-year outcomes after prostatectomy or radiotherapy for prostate cancer: the prostate cancer outcomes study.
    Potosky AL; Davis WW; Hoffman RM; Stanford JL; Stephenson RA; Penson DF; Harlan LC
    J Natl Cancer Inst; 2004 Sep; 96(18):1358-67. PubMed ID: 15367568
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Quality of life after radiotherapy for prostate cancer].
    Joly F; Degrendel AC; Guizard AV
    Cancer Radiother; 2010 Oct; 14(6-7):519-25. PubMed ID: 20728393
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Survivorship beyond convalescence: 48-month quality-of-life outcomes after treatment for localized prostate cancer.
    Gore JL; Kwan L; Lee SP; Reiter RE; Litwin MS
    J Natl Cancer Inst; 2009 Jun; 101(12):888-92. PubMed ID: 19509365
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluation of health-related quality of life in patients with prostate cancer after treatment with radical retropubic prostatectomy and permanent prostate brachytherapy.
    Dragićević S; Naumović T; Soldatović I; Mićić S; Tulić C; Pekmezović T
    Urol Int; 2010; 85(2):173-179. PubMed ID: 20606405
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Health related quality of life patterns in patients treated with interstitial prostate brachytherapy for localized prostate cancer--data from CaPSURE.
    Downs TM; Sadetsky N; Pasta DJ; Grossfeld GD; Kane CJ; Mehta SS; Carroll PR; Lubeck DP
    J Urol; 2003 Nov; 170(5):1822-7. PubMed ID: 14532784
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Survival among men with clinically localized prostate cancer treated with radical prostatectomy or radiation therapy in the prostate specific antigen era.
    Kibel AS; Ciezki JP; Klein EA; Reddy CA; Lubahn JD; Haslag-Minoff J; Deasy JO; Michalski JM; Kallogjeri D; Piccirillo JF; Rabah DM; Yu C; Kattan MW; Stephenson AJ
    J Urol; 2012 Apr; 187(4):1259-65. PubMed ID: 22335870
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A nationwide charge comparison of the principal treatments for early stage prostate carcinoma.
    Brandeis J; Pashos CL; Henning JM; Litwin MS
    Cancer; 2000 Oct; 89(8):1792-9. PubMed ID: 11042575
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Cost comparison of three treatments for localized prostate cancer in Spain: radical prostatectomy, prostate brachytherapy and external 3D conformal radiotherapy].
    Becerra Bachino V; Cots F; Guedea F; Pera J; Boladeras A; Aguiló F; Suárez JF; Gallo P; Murgui L; Pont A; Cunillera O; Pardo Y; Ferrer M;
    Gac Sanit; 2011; 25(1):35-43. PubMed ID: 21316126
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Incidence of urethral stricture after primary treatment for prostate cancer: data From CaPSURE.
    Elliott SP; Meng MV; Elkin EP; McAninch JW; Duchane J; Carroll PR;
    J Urol; 2007 Aug; 178(2):529-34; discussion 534. PubMed ID: 17570425
    [TBL] [Abstract][Full Text] [Related]  

  • 17. How do patients choose between active surveillance, radical prostatectomy, and radiotherapy? The effect of a preference-sensitive decision aid on treatment decision making for localized prostate cancer.
    Lamers RE; Cuypers M; de Vries M; van de Poll-Franse LV; Ruud Bosch JL; Kil PJ
    Urol Oncol; 2017 Feb; 35(2):37.e9-37.e17. PubMed ID: 28341494
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Side-effects of treatment for localized prostate cancer: are they valued differently by patients and healthy controls?
    Korfage IJ; de Koning HJ; Habbema JD; Schröder FH; Essink-Bot ML
    BJU Int; 2007 Apr; 99(4):801-6. PubMed ID: 17233804
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of mortality outcomes after radical prostatectomy versus radiotherapy in patients with localized prostate cancer: a population-based analysis.
    Abdollah F; Schmitges J; Sun M; Jeldres C; Tian Z; Briganti A; Shariat SF; Perrotte P; Montorsi F; Karakiewicz PI
    Int J Urol; 2012 Sep; 19(9):836-44. PubMed ID: 22574746
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Radiation therapy for prostate cancer increases subsequent risk of bladder and rectal cancer: a population based cohort study.
    Nieder AM; Porter MP; Soloway MS
    J Urol; 2008 Nov; 180(5):2005-9; discussion 2009-10. PubMed ID: 18801517
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 33.